Keyphrases
Graft-versus-host Disease (GvHD)
100%
Unrelated Donor Transplantation
100%
Clonal Hematopoiesis
100%
Hazard Ratio
20%
Confidence Interval
20%
Transplant Outcomes
20%
DNA Samples
10%
Progression-free Survival
10%
Platelet Recovery
10%
Old Age
10%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
10%
Therapeutic Intervention
10%
Blood Samples
10%
Transplant-related Mortality
10%
Neutrophil Recovery
10%
Mutated Genes
10%
Myeloid Malignancies
10%
Relapse Incidence
10%
Cardiovascular Complications
10%
Tet Methylcytosine Dioxygenase 2
10%
DNMT3A
10%
ASXL1
10%
Donor Blood
10%
Variant Allele Frequency
10%
Donor DNA
10%
Disease Intervention
10%
PPM1D
10%
Targeted Deep Sequencing
10%
Medicine and Dentistry
Hematopoiesis
100%
Acute Graft Versus Host Disease
100%
Transplantation
40%
Hazard Ratio
20%
Myelodysplastic Syndrome
20%
Acute Myelogenous Leukemia
20%
Progression Free Survival
10%
Platelet
10%
Cardiovascular Disease
10%
Neutrophil
10%
Stem Cell Transplant
10%
Myeloid Malignancy
10%
Blood Donor
10%
Gene Frequency
10%
ASXL1
10%
DNA Methyltransferase 3A
10%
Immunology and Microbiology
Hematopoiesis
100%
Acute Graft Versus Host Disease
100%
Myeloid
10%
Platelet
10%
Gene Frequency
10%
Neutrophil
10%
Stem Cell Transplant
10%
Progression Free Survival
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Graft Versus Host Disease
100%
Myelodysplastic Syndrome
40%
Progression Free Survival
20%
Cardiovascular Disease
20%
DNA Methyltransferase 3A
20%